Vivace Therapeutics

• A Phase 3 Trial in Advanced Epithelioid Mesothelioma

  Phase 3, Not yet recruiting, 350 people, Sep 17, 2026

• Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

  Phase 1/2, Recruiting, 434 people, Dec 11, 2020

Sources: clinicaltrials.gov